Comparing a new surgery to a diabetes drug for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial compares a new surgical procedure (duodeno-ileostomy) to a medication (semaglutide) for people with obesity and type 2 diabetes. It aims to see which approach works better for weight loss and blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a body mass index (BMI) between 30 and 40, meaning you have obesity and need treatment.
- You have type 2 diabetes, confirmed by a recent blood test (HbA1c of 6.5% or higher).
- You are willing to be randomly assigned to either surgery or medication.
- You agree not to have any other weight-loss surgery or take other weight-loss drugs during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.
This study tests whether taking semaglutide (a once-weekly injection that helps control appetite and blood sugar) before and after a second weight-loss surgery can help people who regained weight after an initial sleeve gastrectomy. The goal is to see if the medicine improves weight-loss outcomes compared to surgery alone.
This trial tests a new procedure that uses magnets to reroute part of your small intestine. It is for people with type 2 diabetes or who have had a sleeve gastrectomy and gained weight back. The goal is to see if this magnetic treatment can help with weight loss and diabetes control.
This trial tests whether taking a weekly injection called semaglutide (a type of medicine used for weight loss) for about 16 weeks before weight-loss surgery can help people with a very high BMI prepare for surgery. It may reduce liver fat and make surgery safer, which could lead to better outcomes.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.